S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Urgent alert: open this for a huge profit potential (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
My biggest AI fear (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Tiny Biotech Stock Wins $75 Billion Patent (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Urgent alert: open this for a huge profit potential (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
My biggest AI fear (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Tiny Biotech Stock Wins $75 Billion Patent (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Urgent alert: open this for a huge profit potential (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
My biggest AI fear (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Tiny Biotech Stock Wins $75 Billion Patent (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Urgent alert: open this for a huge profit potential (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
My biggest AI fear (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Tiny Biotech Stock Wins $75 Billion Patent (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Free Trial

Pacira BioSciences (PCRX) Earnings Date, Estimates & Call Transcripts

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free pcrx Stock Alerts
$26.25
+0.15 (+0.57%)
(As of 04/19/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
May. 1Estimated
Actual EPS
(Feb. 29)
$0.71
Consensus EPS
(Feb. 29)
$0.71
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

PCRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PCRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Pacira BioSciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242$0.38$0.53$0.46 
Q2 20242$0.51$0.62$0.57 
Q3 20242$0.46$0.59$0.53 
Q4 20242$0.62$0.73$0.68 
FY 20248$1.97$2.47$2.22 
Q1 20251$0.69$0.69$0.69 
Q2 20251$0.76$0.76$0.76 
Q3 20251$0.72$0.72$0.72 
Q4 20251$0.91$0.91$0.91 
FY 20254$3.08$3.08 $3.08

PCRX Earnings Date and Information

Pacira BioSciences last announced its earnings results on February 29th, 2024. The reported $0.71 earnings per share for the quarter, meeting the consensus estimate of $0.71. The firm earned $181.24 million during the quarter, compared to the consensus estimate of $180.60 million. Pacira BioSciences has generated $0.81 earnings per share over the last year ($0.81 diluted earnings per share) and currently has a price-to-earnings ratio of 32.4. Earnings for Pacira BioSciences are expected to grow by 29.82% in the coming year, from $2.18 to $2.83 per share. Pacira BioSciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off prior year's report dates.

Pacira BioSciences Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/1/2024
Estimated)		------- 
2/29/2024Q4 2023$0.71$0.71-$0.92$180.60 million$181.24 million
11/2/2023Q3 2023$0.65$0.52($0.13)$0.81$172.83 million$163.93 million
8/2/2023Q2 2023$0.59$0.61+$0.02$0.71$175.64 million$169.47 million
5/3/2023Q1 2023$0.40$0.32($0.08)$1.07$157.02 million$160.34 million
2/28/2023Q4 2022$0.71$0.60($0.11)$1.42$174.12 million$171.96 million
11/3/2022Q3 2022$0.40$0.42+$0.02$0.86$167.30 million$167.47 million    
8/3/2022Q2 2022$0.57$0.34($0.23)$0.28$169.27 million$169.41 million      
5/4/2022Q1 2022$0.49$0.45($0.04)$0.75$155.08 million$157.99 million      
2/24/2022Q4 2021$0.60$0.78+$0.18$1.68$157.42 million$159.19 million    
11/2/2021Q3 2021$0.65$0.72+$0.07$0.67$129.69 million$127.70 million    
8/2/2021Q2 2021$0.74$0.77+$0.03$0.78$135.02 million$135.60 million      
5/3/2021Q1 2021$0.64$0.53($0.11)$0.51$119.23 million$119.00 million  

Pacira BioSciences Earnings - Frequently Asked Questions

When is Pacira BioSciences's earnings date?

Pacira BioSciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off last year's report dates. Learn more on PCRX's earnings history.

Did Pacira BioSciences beat their earnings estimates last quarter?

In the previous quarter, Pacira BioSciences (NASDAQ:PCRX) reported $0.71 earnings per share (EPS) to hit the analysts' consensus estimate of $0.71. Learn more on analysts' earnings estimate vs. PCRX's actual earnings.

How much revenue does Pacira BioSciences generate each year?

Pacira BioSciences (NASDAQ:PCRX) has a recorded annual revenue of $674.98 million.

How much profit does Pacira BioSciences generate each year?

Pacira BioSciences (NASDAQ:PCRX) has a recorded net income of $41.96 million. PCRX has generated $0.81 earnings per share over the last four quarters.

What is Pacira BioSciences's price-to-earnings ratio?

Pacira BioSciences (NASDAQ:PCRX) has a trailing price-to-earnings ratio of 32.41 and a forward price-to-earnings ratio of 12.04.

What is Pacira BioSciences's EPS forecast for next year?

Pacira BioSciences's earnings are expected to grow from $2.18 per share to $2.83 per share in the next year, which is a 29.82% increase.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:PCRX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
SHOCKING Crypto Leak…
Crypto 101 Media
The #1 Crypto for 2024
InvestorPlace
How Biden has already won 2024
Porter & Company
Urgent alert: open this for a huge profit potential
Timothy Sykes